Open-House Discount Contracts for Eculizumab (including gMG and NMOSD indications)
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-03b - Eculizumab (inkl. der Indikation gMG und NMOSD)
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume or purchase commitment from the health insurance funds; contracts are discount agreements without...
The tender is explicitly not a public procurement under EU directives; legal recourse lies with social courts, not proc...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Aug 2027
- Supply of pharmaceutical product Eculizumab including indications gMG and NMOSD
- Conclusion of discount contracts under §130a Abs. 8 SGB V
Show full summary
Open-House procedure for discount contracts (Rabattverträge) according to § 130a Abs. 8 SGB V for the active substance Eculizumab including indications generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). The procedure is open to all qualified pharmaceutical entrepreneurs. Contracts have a fixed maximum duration until 31 August 2027, with possible start from 1 April 2026. No estimated value is provided. The tender is not a public procurement under EU directives; it is an Open-House model with no negotiation. Submission is possible at any time until the contract end.
Risks
No guaranteed volume or purchase commitment from the health insurance funds; contracts are discount agreements without...
The tender is explicitly not a public procurement under EU directives; legal recourse lies with social courts, not proc...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG
- Registered office in Germany, EU, or EEA
- Valid marketing authorization for the product or entitlement to market
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-House Discount Contracts for Eculizumab (including gMG and NMOSD indications)
Conclusion of drug discount contracts for Eculizumab (including gMG and NMOSD) under an Open-House procedure. All qualified pharmaceutical entrepreneurs can join at any time during the contract period.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria defined
the notice states criteria are not relevant due to the Open-House nature.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2026-03b - Eculizumab (inkl. der Indikation gMG und NMOSD)
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Eculizumab (inkl. der Indikation gMG und NMOSD) im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 24 Feb 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 133422-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume or purchase commitment from the health insurance funds; contracts are discount agreements without...
The tender is explicitly not a public procurement under EU directives; legal recourse lies with social courts, not proc...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications